Rheumatology: Current Research
Open Access

Andrew Kinloch

Biography

Dr. Andrew kinloch, Ph.D has started his career as B.Sc(Hons)Immunology from University of Glasgow, UK. In 2003 he joined MGH Cancer Center, Harvard University as research trainee. He has recieved his Ph.D  in 2007 for the research on "Discovery of citrullinated antigens targeted by antibodies produced by patients with RA, including citrullinated alpha-enolase. Epitope mapping of citrullinated alpha-enolase and co-inventor of CEP-1 peptide used for detection of RA specific antibodies. Demonstration of the synovial fluid as an extracellular niche in which citrullinated antigens are generated."Presently he is working as a Senoir Post Doctoral Scholar and faculty member in Knapp Center for Lupus & ImmunologyResearch, USA. he is the patent owner with registration no. EP2115134 A1 for the invention of "methods of diagnosing, prognosing, preventing or delaying onset of or treating rheumatoid arthritis, methods of distinguishing between different types or stages of rheumatoid arthritis, of identifying an individual at risk of developing rheumatoid arthritis, and of monitoring efficacy of a treatment regime in an individual being treated for rheumatoid arthritis, using a citrullinated enolase peptide to detect or capture antibodies associated with rheumatoid arthritis."

Research Interest

Generation of monoclonal antibodies from kidney tissue of patients with lupus tubulointerstitial nephritis; Antigen characterization; Mouse model development and serological assay development.